Genfit, Evogene leads healthcare gainers, Rite Aid, Cellect Biotechnology among major losers
Gainers: Genfit (GNFT) +15%, Evogene (EVGN) +13%, Marinus Pharmaceuticals (MRNS) +11%, Endo International (ENDP) +8%, Happiness Biotech Group (HAPP) +7%.Losers: Rite Aid (RAD) -10%, Cellect Biotechnology (APOP) -8%, Kaleido Biosciences (KLDO) -7%, Taiwan Liposome (TLC) -6%, Nephros (NEPH) -6%.
Seekingalpha · 5h ago
Owens & Minor, Kaleido Biosciences among major healthcare gainers, MediciNova, Rite Aid leads losers pack
Gainers: Owens & Minor (OMI) +53%, Kaleido Biosciences (KLDO) +39%, LogicBio Therapeutics (LOGC) +30%, Cellect Biotechnology (APOP) +25%, Neuronetics (STIM) +6%.Losers: MediciNova (MNOV) -20%, Rite Aid (RAD) -17%, ADiTx Therapeutics (ADTX) -12%, NanoVibronix (NAOV) -12%, Rockwell Medical (RMTI) -10%.
Seekingalpha · 1d ago
Cellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the Mesa
Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business CollaborationsTel Aviv, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology which enables the functional selection
GlobeNewswire · 4d ago
Cellect Bio nabs new patent in Europe
European Patent Office has granted Cellect Biotechnology (APOP +3.6%) a Patent Application no. 14851547.1 for Apograft, covering the activation of the stem
seekingalpha · 08/06 18:40
European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property (IP) portfolio as European Patent Application
PR Newswire · 08/06 12:30
Cellect Biotechnology Q1 EPS $(0.002) Up From $(0.008) YoY
Cellect Biotechnology (NASDAQ:APOP) reported quarterly losses of $(0.00) per share. This is a 75 percent increase over losses of $(0.01) per share from the same period last year.
Benzinga · 05/21 20:19
84 Biggest Movers From Yesterday
Benzinga · 05/13 09:31
60 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 05/12 16:26
Company News for May 12, 2020
Zacks · 05/12 15:09
Cellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 Million
GlobeNewswire · 05/12 13:48
GNFT, DT among premarket losers
Seeking Alpha - Article · 05/12 13:19
78 Biggest Movers From Yesterday
Benzinga · 05/12 09:02
Mid-Afternoon Market Update: NASDAQ Rises Over 100 Points; Amneal Pharmaceuticals Shares Surge On Upbeat Results
Toward the end of trading Monday, the Dow traded down 0.11% to 24305.58 while the NASDAQ rose 1.17% to 9228. The S&P also rose, gaining 0.27% to 2,937.69.
Benzinga · 05/11 19:02
AMC, CYTK, MT and SALT among midday movers
Seeking Alpha - Article · 05/11 16:40
54 Stocks Moving In Monday's Mid-Day Session
Benzinga · 05/11 16:39
Mid-Day Market Update: Recro Pharma Falls After Q1 Results; MyoKardia Shares Climb
Midway through trading Monday, the Dow traded down 0.80% to 24135.84 while the NASDAQ rose 0.19% to 9138.42. The S&P also fell, dropping 0.42% to 2917.35.
Benzinga · 05/11 16:29
Why Israeli Stem Cell Therapy Company Cellect Biotech Is Rallying
Shares of nano-cap stem cell therapy company Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) were advancing strongly Monday.
Benzinga · 05/11 15:46
Mid-Morning Market Update: Markets Mostly Lower; Cardinal Health Beats Q3 Estimates
Following the market opening Monday, the Dow traded down 0.83% to 24128.74 while the NASDAQ rose 0.19% to 9,138.91. The S&P also fell, dropping 0.52% to 2,914.59.
Benzinga · 05/11 14:15
CAH, BLUE among premarket gainers
Seeking Alpha - Article · 05/11 13:26
32 Stocks Moving in Monday's Pre-Market Session
Benzinga · 05/11 11:18
Webull provides a variety of real-time APOP stock news. You can receive the latest news about Cellect Bio through multiple platforms. This information may help you make smarter investment decisions.